Advancing the Discovery & Development of Peptide Drugs with Novel Screening, Chemistry, Formulation & CMC to Improve Permeability, Bioavailability & Efficacy Across All Diseases
Peptide therapies are rapidly becoming a disruptive modality, with Unnatural Products scoring a $1.7B deal with Novartis, Vivtex's $2.1B partnership with Novo Nordisk, and Pinnacle Medicines raising $89M for oral peptides, these investments signal a shift in priority for peptide discovery and delivery towards improving chemistry, formulation and ultimately clinical efficacy.
To shine a light on the progress of this field, the highly anticipated 3rd Peptide-Based Therapeutics Summit returned to Boston as the industry’s only dedicated platform, turbocharging the next generation of peptide discoveries and advancing development efforts toward life-saving treatments.
Bringing together industry leaders including Unnatural Products, Vilya Therapeutics, Parabilis Medicines, Circle Pharma, Vivtex, Pinnacle Medicines, Eli Lilly, Protagonist Therapeutics, Merck & Co, Johnson & Johnson, Novo Nordisk, Endevica, Novartis, Peptinovo Biopharma, MBX Biosciences, 20N Bio and many more, this is your premium forum to explore the power of peptide computation, optimizing analytics, improving oral bioavailability and translating the pharmacology with clinical safety.
The event welcomed over 140 stakeholders from CEOs to Scientists in disciplines ranging from peptide drug discovery R&D, medicinal chemistry, pharmacology and formulation to accelerate this goldilocks modality from concept to commercialization.
This Summit will provide a deep learning experience for all peptide drug hunters and an opportunity to meet accomplished R&D leaders as well as share their scientific work as speakers or via poster presentations.
Tomi Sawyer, Maestro Therapeutics
I see the summit as a great opportunity to meet other participants with a strong dedication to peptide therapeutics and who share the goal of oral peptide delivery.
Florian Foeger, Cyprumed
As an investor, I look forward to meeting with the companies and thought leaders at the forefront of the peptide therapeutics space.
Alex Loftis, Vida Ventures
Download the Full Event Guide
- Learn from 40+ Expert Speakers
- NEW Two-Track Agenda covering Drug Discovery and Formulation & CMC
- NEW Business Development & Investment Panel
- 4 Pre-Conference Deep-Dive Workshops
- 25+ Data-Driven Case Studies
Official 2026 Partners
Attending Companies Included
Explore Related Events
Explore the 2026 Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.